You May Also Like

Investigational drug available directly from CDC for the treatment of free-living ameba infections
Cite
CITE Title : Investigational drug available directly from CDC for the treatment of free-living ameba infections Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.);United States. Food and Drug Administration.; Published Date : 08/23/2013 Series : HAN ; 354 URL : https://stacks.cdc.gov/view/cdc/25263 Journal Title : HAN Centers for Disease Control and Prevention (U.S.) (2013). Investigational drug available directly from CDC for the treatment of free-living ameba infections. 354 Centers for Disease Control and Prevention (U.S.) "Investigational drug available directly from CDC for the treatment of free-living ameba infections" 354 (2013) Centers for Disease Control and Prevention (U.S.) "Investigational drug available directly from CDC for the treatment of free-living ameba infections" vol. 354, 2013 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 1.65 MB]
:
Centers for Disease Control and Prevention (U.S.) ...
08/23/2013 | HAN ; 354
Description:
August 23, 2013, 11:30 ET (11:30 AM ET)HANINFO-00354Summary: CDC now has an expanded access investigational new drug (IND) protocol in effect with the...
File Type:
[PDF - 1.65 MB]
File Type:
[PDF - 1.65 MB]

Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of One Fatal and One Surviving Case
Cite
CITE Title : Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of One Fatal and One Surviving Case Personal Author(s) : Cope, Jennifer R.;Conrad, Dennis A.;Cohen, Naiomi;Cotilla, Manuel;DaSilva, Alexandre;Jackson, Jonathan;Visvesvara, Govinda; Published Date : Dec 17 2015 Source : Clin Infect Dis. 62(6):774-776. URL : https://stacks.cdc.gov/view/cdc/38329 Cope, Jennifer R. et al. (2015). Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of One Fatal and One Surviving Case. 62(6). Cope, Jennifer R. et al. "Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of One Fatal and One Surviving Case" 62, no. 6 (2015) Cope, Jennifer R. et al. "Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of One Fatal and One Surviving Case" vol. 62, no. 6, 2015 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 73.90 KB]
Personal Author:
Cope, Jennifer R. ;
Conrad, Dennis A.
...
Dec 17 2015 | Clin Infect Dis. 62(6):774-776.
Description:
Primary amebic meningoencephalitis (PAM) is a fulminant central nervous system infection caused by the thermophilic free-living ameba Naegleria fowler...
File Type:
[PDF - 73.90 KB]
File Type:
[PDF - 73.90 KB]